Donald Robert Schemel - Oct 4, 2022 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role: Director, 10%+ Owner
Signature: /s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol: PBLA
Transactions as of: Oct 4, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/6/2022, 05:26 PM
Previous filing: May 27, 2021
Next filing: Mar 29, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PBLA	Common Stock	Purchase		+200K	+70.76%		483K	Oct 4, 2022	By Spouse	F1
holding	PBLA	Common Stock						96.6K	Oct 4, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PBLA	Warrants (right to buy)	Purchase	$0	+300K		$0.00	300K	Oct 4, 2022	Common Stock	300K	$0.30	By Spouse

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reported securities purchased as one share of common stock and one warrant to purchase one share of common stock for a combined price of $0.30 per share and warrant.